Filtros : "Abriata, Juliana Palma" "Estados Unidos" "2020" Limpar

Filtros



Refine with date range


  • Source: Biotechnology Progress. Unidade: FCFRP

    Subjects: NEOPLASIAS OVARIANAS, FÁRMACOS, BIOTECNOLOGIA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TOFANI, Larissa Bueno et al. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, v. 36, n. 6, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1002/btpr.3034. Acesso em: 02 nov. 2024.
    • APA

      Tofani, L. B., Abriata, J. P., Luiz, M. T., Marchetti, J. M., & Swiech, K. (2020). Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, 36( 6), 1-11. doi:10.1002/btpr.3034
    • NLM

      Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1002/btpr.3034
    • Vancouver

      Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1002/btpr.3034

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024